Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersOphthalmology Physician in Layton, UT
NPI: 1184923807Primary Practice Location
HOLY CROSS HOSPITAL-DAVIS
1600 W Antelope Dr, Layton, UT
Primary Employer
Tanner Memorial Clinic
tannerclinic.com
HQ Phone
Get M.D. Trent's Phone Numberphone_androidMobile
Get M.D. Trent's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardUT State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 261 | 292 |
| 2 | 92012Eye and medical examination for diagnosis and treatment, established patient | 168 | 249 |
| 3 | 92004Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | 152 | 152 |
| 4 | 92250Photography of the retina | 118 | 119 |
| 5 | 92134Diagnostic imaging of retina | 89 | 106 |
Cerebrovasospasm following endoscopic cerebrospinal fluid leak repair.
Authors: Jason Hunt
Journal: Skull Base
Lead Sponsor: Surface Ophthalmics, Inc.
Intervention / Treatment: DRUG: Lifitegrast 5% Ophthalmic Solution, DRUG: SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate), DRUG: Mycophenolic Acid 0.1%, DRUG: Mycophenolic Acid 0.3%, DRUG: Betamethasone Sodium Phosphate 0.01%, DRUG: Placebo Comparator: Vehicle, DRUG: Cyclosporine 0.05% Ophthalmic Emulsion
Lead Sponsor: Kala Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Vehicle of KPI-121 0.25% Ophthalmic Suspension, DRUG: KPI-121 0.25% Ophthalmic Suspension
